We analyzed mRNA expression levels of PAIPs CIP2A, PME1, TIPRL, SET and ARPP19 by real-time quantitative PCR (RQ-PCR) from 80 diagnosis phase AML patients’ bone marrow (BM) samples. This evidence concerns the gene CIP2A and acute myeloid leukemia.